Abstract:Alzheimer’s disease (AD) is a complex heterogeneous neurodegenerative disease that requires an in-depth understanding of its progression pathways and contributing factors to develop effective risk stratification and prevention strategies. In this study, we proposed an outcome-oriented model to identify progression pathways from mild cognitive impairment (MCI) to AD using electronic health records (EHRs) from the OneFlorida+ Clinical Research Consortium. To achieve this, we employed the long short-term memory (LSTM) network to extract relevant information from the sequential records of each patient. The hierarchical agglomerative clustering was then applied to the learned representation to group patients based on their progression subtypes. Our approach identified multiple progression pathways, each of which represented distinct patterns of disease progression from MCI to AD. These pathways can serve as a valuable resource for researchers to understand the factors influencing AD progression and to develop personalized interventions to delay or prevent the onset of the disease.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementThis work was partially supported by a grant from the Ed and Ethel Moore Alzheimer's Disease Research Program of the Florida Department of Health (FL DOH #23A09) and grants (R01AG080624, R01AG080991, R01AG076234, and UL1TR001427) from the National Institutes of Health (NIH).### Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study has been approved by the University of Florida Institutional Review Board (protocol no. IRB202202820).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes

Employing Informatics Strategies in Alzheimer's Disease Research: A Review from Genetics, Multiomics, and Biomarkers to Clinical Outcomes

Advancing Alzheimer's Research: A Review of Big Data Promises

Applied machine learning in Alzheimer's disease research: omics, imaging, and clinical data

Identification of Outcome-Oriented Progression Subtypes from Mild Cognitive Impairment to Alzheimer’s Disease Using Electronic Health Records

A Review of Brain Imaging Biomarker Genomics in Alzheimer’s Disease: Implementation and Perspectives

Applications and Challenges of Machine Learning Methods in Alzheimer's Disease Multi-Source Data Analysis

AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling

A review and analysis of key biomarkers in Alzheimer's disease

Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease

The Research Progress of the Application of Bioinformatics in the Diagnosis and Treatment of Alzheimer's Disease

New molecular approaches to Alzheimer's disease

Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer’s disease: review, recommendation, implementation and application

Neuroimaging techniques, gene therapy, and gut microbiota: frontier advances and integrated applications in Alzheimer's Disease research

Brain-wide Genome-Wide Colocalization Study for Integrating Genetics, Transcriptomics and Brain Morphometry in Alzheimer's Disease

Multi-omics Analysis Reveals the Key Factors Involved in the Severity of the Alzheimer’s Disease

Alzheimer's Disease: Exploring the Landscape of Cognitive Decline

Multimodal Identification of Alzheimer's Disease: A Review

The Application of Artificial Intelligence in Alzheimer's Research

Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease

Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease